Word

OCQUILA

Status

Dead

Status Code

710

Status Date

Friday, December 1, 2017

Serial Number

77673792

Registration Number

3949710

Registration Date

Tuesday, April 26, 2011

Mark Type

4000

Filing Date

Thursday, February 19, 2009

Published for Opposition

Tuesday, February 8, 2011

Cancellation Date

Friday, December 1, 2017

Trademark Owner History

Oxford BioMedica (UK) Limited - Original Registrant

Classifications

1 Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory and scientific research and development use in biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, all of the foregoing for in-vivo use

5 Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical purposes in connection with gene therapy, pharmaceuticals for medical purposes for the delivery of genes to cells; viral, retroviral and non-viral vectors, and manufacturing preparations for viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; biochemical and chemical preparations for medical purposes in gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes

10 Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes

42 Scientific, pharmaceutical and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology, advisory services relating to the research and development of gene therapy products and clinical trials, conducting clinical trials

44 Medical services; advisory services relating to vaccination regimens; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, in humans and animals, and advisory services relating to the use of pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals

Trademark Events

Dec 1, 2017

Cancelled Sec. 8 (6-Yr)

Apr 26, 2011

Registered-Principal Register

Feb 8, 2011

Official Gazette Publication Confirmation E-Mailed

Feb 8, 2011

Published For Opposition

Jan 6, 2011

Law Office Publication Review Completed

Jan 5, 2011

Approved For Pub - Principal Register

Jan 5, 2011

Teas/Email Correspondence Entered

Jan 5, 2011

Correspondence Received In Law Office

Jan 4, 2011

Assigned To Lie

Dec 7, 2010

Teas Response To Suspension Inquiry Received

Jun 7, 2010

Notification Of Inquiry As To Suspension E-Mailed

Jun 7, 2010

Inquiry To Suspension E-Mailed

Jun 7, 2010

Suspension Inquiry Written

Dec 1, 2009

Notification Of Letter Of Suspension E-Mailed

Dec 1, 2009

Letter Of Suspension E-Mailed

Dec 1, 2009

Suspension Letter Written

Nov 20, 2009

Teas/Email Correspondence Entered

Nov 20, 2009

Correspondence Received In Law Office

Nov 20, 2009

Assigned To Lie

Nov 9, 2009

Teas Response To Office Action Received

May 18, 2009

Notification Of Non-Final Action E-Mailed

May 18, 2009

Non-Final Action E-Mailed

May 18, 2009

Non-Final Action Written

May 11, 2009

Assigned To Examiner

Feb 23, 2009

New Application Office Supplied Data Entered In Tram

Feb 23, 2009

New Application Entered In Tram